Question 1

Does Centiva Capital own TXG stock?

Accepted Answer

No. Centiva Capital exited its TXG (10x Genomics) position in Q2 2025. Its Q1 2025 13F listed 60,090 shares worth $524,586.

Question 2

How many shares of TXG does Centiva Capital own?

Accepted Answer

None since Q2 2025, when Centiva Capital exited the position. Its Q1 2025 13F listed 60,090 shares worth $524,586.

Question 3

What is Centiva Capital's TXG position worth?

Accepted Answer

Centiva Capital's TXG position was worth $524,586 in its Q1 2025 13F, before the exit in Q2 2025.

Question 4

Is Centiva Capital buying or selling TXG?

Accepted Answer

In Q2 2025, Centiva Capital exited its entire TXG position.

Question 5

When did Centiva Capital first buy TXG?

Accepted Answer

Centiva Capital first reported TXG in its Q2 2021 13F and listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2025-Q2 Latest	Exited	0	-100.0%	$0	0.0%	$11.58	0
2025-Q1	Increased	60,090	+185.3%	$524,586	0.0%	$8.73	39
2024-Q4	New	21,062	—	$302,450	0.0%	$14.36	32